Suppr超能文献

甲状腺功能减退症血脂异常的最新进展:甲状腺功能减退症血脂异常的机制

Update on dyslipidemia in hypothyroidism: the mechanism of dyslipidemia in hypothyroidism.

作者信息

Liu Huixing, Peng Daoquan

机构信息

Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.

出版信息

Endocr Connect. 2022 Feb 7;11(2):e210002. doi: 10.1530/EC-21-0002.

Abstract

Hypothyroidism is often associated with elevated serum levels of total cholesterol, LDL-C and triglycerides. Thyroid hormone (TH) affects the production, clearance and transformation of cholesterol, but current research shows that thyroid-stimulating hormone (TSH) also participates in lipid metabolism independently of TH. Therefore, the mechanism of hypothyroidism-related dyslipidemia is associated with the decrease of TH and the increase of TSH levels. Some newly identified regulatory factors, such as proprotein convertase subtilisin/kexin type 9, angiogenin-like proteins and fibroblast growth factors are the underlying causes of dyslipidemia in hypothyroidism. HDL serum concentration changes were not consistent, and its function was reportedly impaired. The current review focuses on the updated understanding of the mechanism of hypothyroidism-related dyslipidemia.

摘要

甲状腺功能减退常伴有血清总胆固醇、低密度脂蛋白胆固醇和甘油三酯水平升高。甲状腺激素(TH)影响胆固醇的产生、清除和转化,但目前的研究表明,促甲状腺激素(TSH)也独立于TH参与脂质代谢。因此,甲状腺功能减退相关血脂异常的机制与TH降低和TSH水平升高有关。一些新发现的调节因子,如前蛋白转化酶枯草杆菌蛋白酶/kexin 9型、血管生成素样蛋白和成纤维细胞生长因子是甲状腺功能减退血脂异常的潜在原因。高密度脂蛋白血清浓度变化不一致,据报道其功能受损。本综述重点关注对甲状腺功能减退相关血脂异常机制的最新认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f81/8859969/6549aac93a6a/EC-21-0002fig1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验